Drug Shortage Report for PENICILLIN G SODIUM FOR INJECTION, USP
| Report ID | 226550 |
| Drug Identification Number | 02220296 |
| Brand name | PENICILLIN G SODIUM FOR INJECTION, USP |
| Common or Proper name | PENICILLIN G SODIUM FOR INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | PENICILLIN G |
| Strength(s) | 10000000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 50 mL |
| ATC code | J01CE |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-05-15 |
| Actual start date | |
| Estimated end date | 2024-06-15 |
| Actual end date | 2024-06-12 |
| Shortage status | Resolved |
| Updated date | 2024-06-13 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Penicillin G Sodium for Injection, USP 10 million units SD Vial 50 mL effective May 15, 2024, until June 15, 2024 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-06-13 | English | Compare |
| v5 | 2024-06-10 | French | Compare |
| v4 | 2024-06-10 | English | Compare |
| v3 | 2024-05-16 | English | Compare |
| v2 | 2024-04-29 | French | Compare |
| v1 | 2024-04-29 | English | Compare |
Showing 1 to 6 of 6